Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer

Oncolytic virotherapy is a promising therapeutic approach for the treatment of cancer. TG6002 is a recombinant oncolytic vaccinia virus deleted in the thymidine kinase and ribonucleotide reductase genes and armed with the suicide gene FCU1, which encodes a bifunctional chimeric protein that efficien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Oncolytics
Autores principales: Béguin, Jérémy, Foloppe, Johann, Maurey, Christelle, Laloy, Eve, Hortelano, Julie, Nourtier, Virginie, Pichon, Christelle, Cochin, Sandrine, Cordier, Pascale, Huet, Hélène, Quemeneur, Eric, Klonjkowski, Bernard, Erbs, Philippe
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533293/
https://ncbi.nlm.nih.gov/pubmed/33072863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.08.020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares